A new drug may boost dwindling treatment options for gonorrhea

In a clinical trial, zoliflodacin was effective against the sexually transmitted disease

gonorrhea bacteria

RESIST Bacteria that cause gonorrhea (Neisseria gonorrhoeae, illustrated) have developed resistance to numerous antibiotics over the years, rendering the drugs unable to kill the microbes.

James Archer/CDC

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content